Press Release
For Release Noon, ET
Thursday, January 23, 2003
January 23, 2003
Contact: CDC, Media Relations
(404) 639-3286
CDC Issues Recommendations Designed to Prevent Hepatitis
Infections in Correctional Settings
The Centers for Disease Control and Prevention (CDC) today published
recommendations designed to prevent and control viral hepatitis infections
in correctional settings. Implementation of these recommendations can reduce
transmission of hepatitis infections among adults at risk in both
correctional facilities and the outside community. Its estimated that 12
percent to 15 percent of all Americans with chronic hepatitis B virus (HBV)
and 39 percent of those with hepatitis C virus (HCV) infections were
released from a correctional facility during the previous year.
The report
which is published in the January 24 issue of CDCs Morbidity and
Mortality Weekly Report (MMWR), Recommendations and Reports
Series consolidates previous recommendations and adds new ones.
Individuals who spend time in jails, prisons and juvenile institutions
have an increased risk of infectious disease, including high rates of
infections with hepatitis B and hepatitis C virus. They also have high rates
of certain risk behaviors, such as the use of injectable drugs, which expose
them to infections with HBV and HCV.
The recommendations were developed following a meeting of experts
convened by CDC in March, 2001. Corrections and public health professionals
as well as experts in liver and infectious diseases reviewed existing and
new research data of hepatitis infections in correctional facilities. The
January 24 MMWR recommendations address incarcerated juveniles and
adults, and covers topics including identification, reporting and
investigation of cases of acute viral hepatitis; hepatitis A and hepatitis B
immunization; testing to identify persons infected with chronic HBV and HCV
infection, or immunity to infections; counseling to prevent HCV infections
and its consequences; medical evaluation of inmates with HBV and HCV
infection; and health education. The recommendations also address the
protection of correctional officers form hepatitis infection.
We believe these recommendations will provide a useful framework for the
development of policies by corrections and public health agencies to prevent
and control viral hepatitis among inmates of correctional facilities, said
Dr. Cindy Weinbaum, CDC epidemiologist and lead author of the report and
recommendations.
The key CDC recommendations include:
- All persons under correctional jurisdiction are at higher risk of a
hepatitis infection, and should therefore be vaccinated against hepatitis
B, unless they have been previously vaccinated or have been previously
infected with hepatitis B and presumably are immune to reinfection;
- Medical evaluation in a correctional facility should include a
behavioral risk assessment and inmates with risk factors should be tested
for HCV infection;
- Inmates who test positive for HCV should be evaluated for chronic
infection and the extent of liver disease;
- Inmates with chronic hepatitis C should be evaluated for antiviral
treatment, which should be considered based on criteria developed by each
jurisdiction and incorporate current treatment guidelines;
- Substance abuse treatment is recommended for persons with chronic
hepatitis B or C infection to limit disease transmission, HCV
re-infection, and progression of chronic liver disease;
- Education regarding the prevention of viral hepatitis should be made
part of health education programs for all correctional facility inmates.
For more information about hepatitis, visit CDCs Web site at
www.cdc.gov/hepatitis.
# # #
CDC protects people's health and safety by preventing and controlling
diseases and injuries; enhances health decisions by providing credible
information on critical health issues; and promotes healthy living through
strong partnerships with local, national, and international organizations. |